A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Head and Neck Cancer|Liver Cancer|Breast Cancer|Gastric Cancer|Non-Small Cell Lung Cancer
Interventions: DRUG: CUDC-101|DRUG: CUDC-101
Sponsor: Curis, Inc.